Next, to evaluate the therapeutic effects of JAK2 depletion on CSCs in vivo, we isolated cancer cells from the primary tumors of CRC xenograft mice (Fig. 2a) and analyzed their cancer-repopulating efficiency by the LDA. The gene discussed is JAK2; the disease is cancer.